Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome
Open Access
- 7 October 2024
- journal article
- review article
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (10) , 101780
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
- KU Leuven
This publication has 104 references indexed in Scilit:
- Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trialThe Lancet, 2000
- The role of psychological and biological factors in postinfective gut dysfunctionGut, 1999
- Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy.Gut, 1997
- Altered rectal perception is a biological marker of patients with irritable bowel syndromeGastroenterology, 1995
- Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndromeGastroenterology, 1994
- Terminal ileal mucosal mast cells in irritable bowel syndromeDigestive Diseases and Sciences, 1993
- Tolerance for Rectosigmoid Distention in Irritable Bowel SyndromeGastroenterology, 1990
- Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome.Gut, 1989
- The Irritable Bowel: A Pathological or a Psychological Syndrome?Journal of the Royal Society of Medicine, 1988
- Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndromeGut, 1973